SPARCL1 and hypertriglyceridemia: This is the first study found that serum Sparcl1 was significantly associated with decreased prevalent risk of hypertriglyceridemia and dyslipidemia in Chinese adults, suggesting the importance of Sparcl1 in the metabolic regulation, especially lipid metabolism.